Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) & Region - Global Forecast to 2026
The global Cell Dissociation Market boasts a total value of $282 million in 2021 and is projected to register a growth rate of 14.7% to reach a value of $561 million by 2026. Factors such as growing government support for cell-based research, increasing research and development initiatives by biopharmaceutical companies and a growing focus on personalized medicine wherein cell dissociation plays a vital role are driving the growth of this market. However, the cell-based research activities are associated with high costs which is expected to restrain the market growth to certain extent.
To know about the assumptions considered for the study, download the pdf brochure
Cell dissociation Market Dynamics
DRIVERS: Growth in research and development initiatives by biopharmaceutical companies
The top companies in the biopharmaceutical industry are focusing on R&D in various therapeutic areas to introduce new drugs in the market. Therefore, there have been heavy investments in various research activities such as clinical trials, efficacy studies, and toxicity studies. Most of these studies require tissue dissociation products in order to isolate cells from primary tissues. This is likely to boost the demand for cell dissociation products.
OPPORTUNITIES: Emerging economies
Emerging economies, such as China, India, and Brazil, are expected to offer significant growth opportunities for players operating in the cell dissociation market. There has been a rise in the R&D projects in the life sciences field in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D to introduce new drugs into the market. Cadila Healthcare Ltd., an India-based pharmaceutical company, spent USD 113 million on R&D in 2020, an increase of 13% over 2019. Similarly, Biocon, another India-based pharmaceutical company, spent USD 58.79 million on R&D in 2020, an increase of 52% over 2019. Such investments are expected to increase the demand for cell dissociation products in the country.
CHALLENGES: Ethical concerns associated with research in cell biology
The cell biology research necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies. These animal and human cells are also used for in vivo toxicity and pharmacokinetic testing of drugs. This is because direct human or animal testing would be harmful and even fatal. Additionally, stem cell research studies use human embryos for clinical applications that often lead to their destruction. In order to monitor these activities, strict regulations have been formulated by ethical authorities in various countries across the globe. Authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others, have implemented stringent regulations for cell biology research. These ethical concerns and restrictions on the use of cells for research are limiting cell biology research to a great extent in various countries across the globe.
The non-enzymatic dissociation segment is expected to grow at the highest CAGR during the forecast period
On the basis of product, the cell dissociation market is segmented into Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments & accessories. The non-enzymatic dissociation products segment is projected to witness the highest growth during the forecast period. This can be attributed to factors such as growth in the demand for non-enzymatic dissociation products owing to their advantages, such as ready-to-use and non-toxic nature, maximized yield of viable cells during the dissociation process.
The tissue dissociation segment accounted for the largest share of the cell dissociation market in 2020
Based on the types, the cell dissociation market is segmented tissue dissociation and cell detachment. The Tissue dissociation segment accounted for the largest market share in 2020. The large share of this segment can be attributed to factors such as increase in the R&D expenditure in the pharmaceutical industry and the rising government funding for chronic disease research.
Pharmaceutical and Biotechnology companies accounted for the largest share of the cell dissociation market in 2020
Based on end-users, the cell dissociation market is segmented into pharmaceutical & biotechnology companies, research & academic institutes, and other end users (contract research organizations and stem cell banks). Pharmaceutical and Biotechnology industries segment accounted for the largest share of the cell dissociation market in 2020. The increasing R&D investments in the pharmaceutical and biotechnology companies is the major driving factor for this market.
North America accounted for the largest share of the cell dissociation market in 2020
Based on the region, the cell dissociation market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the cell dissociation market. The large share of North America can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the dominant presence of key market players in this region.
Cell Dissociation Market Key Players
Some of the major players operating in this market are Thermo Fishers Scientific(US), Merck KgaA (Germany), Roche Diagnostics (Switzerland), and Becton, Dickinson and Company (US). In 2020, Thermo Fishers Scientific held the leading position in the market. The company has a strong geographic presence across the US, Asia, Europe, Middle East and Africa, & the Americas. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the cell dissociation market is its key strength. Merck KgaA held the second position in the cell dissociation market in 2020.
Cell Dissociation Market Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size Available for Years |
2016–2026 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2021–2026 |
|
Forecast Units |
Value (USD Million) |
|
Segments Covered |
Products, Cell Type, Tissue, End User and Region |
|
Geographies Covered |
North America (US, Canada), Europe (Germany, France, UK, Spain, Italy, and RoE), APAC (China, India, Japan and the RoAPAC), and Rest of the World |
|
Companies Covered |
Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), PromoCell GmbH (Germany), AcceGen(US), VitaCyte (US), Alstem (US), Biological Industries (Israel), Gemini Bio (US), Innovative Cell Technologies (US), Central Drug House (India), Worthington Biochemical Corporation (US), Capricorn Scientific (Germany), Abeomics (US), Genlantis (US), and Neuromics (US)
|
This research report categorizes the cell dissociation market into the following segments and subsegments:
Product
-
Enzymatic Dissociation Products
- Collagenase
- Trypsin
- Papain
- Elastase
- DNase
- Hyaluronidase
- Other Enzymes
- Enzymatic Dissociation Products
- Instruments
Tissue
- Connective Tissues
- Epithelial Tissues
- Other type tissues (skeletal and muscles tisues)
Type
- Tissue dissociation
- Cell detachment
End User
- Pharmaceutical and Biotechnology companies
- Research and Academics
- other end users
Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Spain
- Italy
- RoE
-
Asia Pacific
- China
- India
- Japan
- RoAPAC
- Rest of the World
Recent Developments:
- In 2020, Thermo Fisher Scientific Collaborated with Symphogen (Denmark) to Extended its strategic collaboration with Symphogen to advance biopharmaceutical discovery and development. Thermo Fisher Scientific Acquired QIAGEN N.V. (Germany) to expand its Specialty Diagnostics portfolio.
- In 2021, Roche Diagnostics Signed a definitive merger agreement with GenMark Diagnostics to access novel technologies to test for a broad range of pathogens in one patient sample.
Frequently Asked Questions (FAQs):
What is the size of Cell Dissociation Market ?
The global Cell Dissociation Market is projected to reach USD 561 million by 2026, growing at a CAGR of 14.7%.
What are the major growth factors of Cell Dissociation Market ?
Factors such as growing government support for cell-based research, increasing research and development initiatives by biopharmaceutical companies and a growing focus on personalized medicine wherein cell dissociation plays a vital role are driving the growth of this market. However, the cell-based research activities are associated with high costs which is expected to restrain the market growth to certain extent.
Who all are the prominent players of Cell Dissociation Market ?
Some of the major players operating in this market are Thermo Fishers Scientific(US), Merck KgaA (Germany), Roche Diagnostics (Switzerland), and Becton, Dickinson and Company (US). .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 MARKET OVERVIEW (Page No. - 46)
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
FIGURE 10 CELL DISSOCIATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
3.2.1 DRIVERS
3.2.1.1 Increasing R&D activities in biopharmaceutical companies
TABLE 1 R&D EXPENDITURE OF MAJOR BIOPHARMACEUTICAL COMPANIES, 2019 VS. 2020
3.2.1.2 Favorable funding scenario for cancer research
FIGURE 11 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION)
3.2.1.3 Increasing incidence and prevalence of chronic and infectious diseases
TABLE 2 RISING GLOBAL INCIDENCE OF DISEASES
3.2.1.4 Growing focus on personalized medicine
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2020
3.2.1.5 Increasing government funding for cell-based research
3.2.2 RESTRAINTS
3.2.2.1 High cost of cell-based research
3.2.2.2 Lack of infrastructure for cell-based research in emerging economies
3.2.3 OPPORTUNITIES
3.2.3.1 Growth opportunities in emerging markets
3.2.3.2 Growth in stem cell research
3.2.3.3 Emergence of advanced tissue dissociation enzyme products
3.2.3.4 Acceptance of enzyme-free dissociation products over enzymatic dissociation products
3.2.4 CHALLENGES
3.2.4.1 Survival of small players and new entrants
3.2.4.2 Ethical concerns regarding research in cell biology
3.3 COVID-19 IMPACT ANALYSIS
4 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 12 CELL DISSOCIATION MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 13 CELL DISSOCIATION MARKET, BY TISSUE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 CELL DISSOCIATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 CELL DISSOCIATION MARKET, BY END USER, 2021 VS. 2021 (USD MILLION)
FIGURE 16 CELL DISSOCIATION MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
5 PREMIUM INSIGHTS (Page No. - 58)
5.1 CELL DISSOCIATION MARKET OVERVIEW
FIGURE 17 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
5.2 CELL DISSOCIATION MARKET, BY PRODUCT
FIGURE 18 ENZYMATIC DISSOCIATION PRODUCTS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
5.3 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE AND COUNTRY, 2020
FIGURE 19 US DOMINATED THE NORTH AMERICAN CELL DISSOCIATION MARKET IN 2020
5.4 GEOGRAPHICAL SNAPSHOT OF THE CELL DISSOCIATION MARKET
FIGURE 20 INDIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
6 CELL DISSOCIATION MARKET, BY PRODUCT (Page No. - 60)
6.1 INTRODUCTION
TABLE 4 CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 5 CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
6.2 ENZYMATIC DISSOCIATION PRODUCTS
6.2.1 COLLAGENASE ACCOUNTED FOR THE LARGEST SHARE OF THE ENZYMATIC DISSOCIATION PRODUCTS MARKET IN 2020
TABLE 6 ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 7 ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
6.2.2 COLLAGENASE
TABLE 8 COLLAGENASE MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 9 COLLAGENASE MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.3 TRYPSIN
TABLE 10 TRYPSIN MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 11 TRYPSIN MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.4 PAPAIN
TABLE 12 PAPAIN MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 13 PAPAIN MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.5 ELASTASE
TABLE 14 ELASTASE MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 15 ELASTASE MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.6 DNASE
TABLE 16 DNASE MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 17 DNASE MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.7 HYALURONIDASE
TABLE 18 HYALURONIDASE MARKET, BY REGION, 2016–2029 (USD MILLION)
TABLE 19 HYALURONIDASE MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.8 OTHER ENZYMES
TABLE 20 OTHER ENZYMES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 21 OTHER ENZYMES MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3 NON-ENZYMATIC DISSOCIATION PRODUCTS
6.3.1 NON-ENZYMATIC DISSOCIATION PRODUCTS MAXIMIZE THE YIELD OF VIABLE CELLS DURING THE DISSOCIATION PROCESS
TABLE 22 NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 23 NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.4 INSTRUMENTS & ACCESSORIES
6.4.1 THE INCREASING PREVALENCE OF CELL-BASED RESEARCH DRIVES THE MARKET GROWTH FOR TISSUE DISSOCIATORS AND ACCESSORIES
TABLE 24 CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 25 CELL DISSOCIATION INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2020–2026 (USD MILLION)
7 CELL DISSOCIATION MARKET, BY TISSUE (Page No. - 72)
7.1 INTRODUCTION
TABLE 26 CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 27 CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
7.2 CONNECTIVE TISSUE
7.2.1 THE CONNECTIVE TISSUE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE CELL DISSOCIATION MARKET IN 2020
TABLE 28 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION, 2016–2019 (USD MILLION)
TABLE 29 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION, 2020–2026 (USD MILLION)
7.3 EPITHELIAL TISSUE
7.3.1 THE EPITHELIAL TISSUE SEGMENT ACCOUNTED FOR THE SECOND-LARGEST SHARE OF THE CELL DISSOCIATION MARKET IN 2020
TABLE 30 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION, 2016–2019 (USD MILLION)
TABLE 31 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION, 2020–2026 (USD MILLION)
7.4 OTHER TISSUES
TABLE 32 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION, 2016–2019 (USD MILLION)
TABLE 33 CELL DISSOCIATION MARKET FOR OTHER TISSUES, BY REGION, 2020–2026 (USD MILLION)
8 CELL DISSOCIATION MARKET, BY TYPE (Page No. - 78)
8.1 INTRODUCTION
TABLE 34 CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 35 CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
8.2 TISSUE DISSOCIATION
8.2.1 INCREASING R&D EXPENDITURE IN THE PHARMACEUTICAL INDUSTRY DRIVES SEGMENT GROWTH
TABLE 36 CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY REGION, 2016–2019 (USD MILLION)
TABLE 37 CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY REGION, 2020–2026 (USD MILLION)
8.3 CELL DETACHMENT
8.3.1 CELL DETACHMENT IS PERFORMED IN STEM CELL & CELL CULTURE STUDIES
TABLE 38 CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY REGION, 2016–2019 (USD MILLION)
TABLE 39 CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY REGION, 2020–2026 (USD MILLION)
9 CELL DISSOCIATION MARKET, BY END USER (Page No. - 83)
9.1 INTRODUCTION
TABLE 40 CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 41 CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 INCREASING INVESTMENTS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 42 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 43 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2026 (USD MILLION)
9.3 RESEARCH & ACADEMIC INSTITUTES
9.3.1 GROWING FUNDING FOR CELL-BASED RESEARCH DRIVES THE MARKET GROWTH
TABLE 44 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2016-2019 (USD MILLION)
TABLE 45 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2020–2026 (USD MILLION)
9.4 OTHER END USERS
TABLE 46 RECENT MERGERS & ACQUISITIONS AMONG CONTRACT RESEARCH ORGANIZATIONS
TABLE 47 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 48 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)
10 CELL DISSOCIATION MARKET, BY REGION (Page No. - 90)
10.1 INTRODUCTION
TABLE 49 CELL DISSOCIATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 50 CELL DISSOCIATION MARKET, BY REGION, 2020–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT
TABLE 51 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 52 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 54 NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 55 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 56 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 57 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 58 NORTH AMERICA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 59 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 60 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.2.1 US
10.2.1.1 The presence of an established pharmaceutical & biotechnology sector drives market growth for cell dissociation products
TABLE 61 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 62 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 63 US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 64 US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 65 US: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 66 US: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 67 US: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 68 US: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 69 US: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 70 US: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Advancements in the field of regenerative medicine to drive market growth in Canada
TABLE 71 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 72 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 73 CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 74 CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 75 CANADA: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 76 CANADA: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 77 CANADA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 78 CANADA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 79 CANADA: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 80 CANADA: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3 EUROPE
TABLE 81 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 82 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 83 EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 84 EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 85 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 86 EUROPE: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 87 EUROPE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 88 EUROPE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 89 EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 90 EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominated the market in Europe in 2020
TABLE 91 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 92 GERMANY: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 93 GERMANY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 94 GERMANY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 95 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 96 GERMANY: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 97 GERMANY: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 98 GERMANY: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 99 GERMANY: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 100 GERMANY: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Government investments in the biotech industry to support market growth in the UK
TABLE 101 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 102 UK: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 103 UK: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 104 UK: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 105 UK: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 106 UK: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 107 UK: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 108 UK: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 109 UK: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 110 UK: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing R&D investments by key players to support market growth in France
TABLE 111 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 112 FRANCE: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 113 FRANCE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 114 FRANCE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 115 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 116 FRANCE: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 117 FRANCE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 118 FRANCE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 119 FRANCE: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 120 FRANCE: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Large life sciences research base in Italy supports market growth for cell dissociation products
TABLE 121 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 122 ITALY: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 123 ITALY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 124 ITALY: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 125 ITALY: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 126 ITALY: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 127 ITALY: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 128 ITALY: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 129 ITALY: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 130 ITALY: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing private & public funding to boost the market growth in Spain
TABLE 131 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 132 SPAIN: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 133 SPAIN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 134 . SPAIN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 135 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 136 SPAIN: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 137 SPAIN: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 138 SPAIN: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 139 SPAIN: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 140 SPAIN: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 141 ROE: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 142 ROE: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 143 ROE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 144 ROE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 145 ROE: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 146 ROE: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 147 ROE: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 148 ROE: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 149 ROE: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 150 ROE: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT
TABLE 151 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 152 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 153 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 154 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 156 ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 157 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 158 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 160 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 162 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Strategic developments by companies to drive the market growth for products in Japan
TABLE 163 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 164 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 165 JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 166 JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 167 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 168 JAPAN: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 169 JAPAN: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 170 JAPAN: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 171 JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 172 JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China to register the highest growth rate in the Asia Pacific market during the forecast period
TABLE 173 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 174 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 CHINA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 176 CHINA: DISSOCIATION PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 CHINA: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 178 CHINA: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 179 CHINA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 180 CHINA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 181 CHINA: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 182 CHINA: CELL DISSOCIATION MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growth initiatives to promote the life sciences industry to drive market growth in India
TABLE 183 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 184 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 185 INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 186 INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 187 INDIA: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 188 INDIA: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 189 INDIA: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 190 INDIA: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 191 INDIA: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 192 INDIA: CELL DISSOCIATION MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 193 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 194 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 195 ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 196 ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 198 ROAPAC: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 199 ROAPAC: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 200 ROAPAC: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 201 ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 202 ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 203 ROW: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 204 ROW: CELL DISSOCIATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 205 ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 206 ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 207 ROW: CELL DISSOCIATION MARKET, BY TISSUE, 2016–2019 (USD MILLION)
TABLE 208 ROW: CELL DISSOCIATION MARKET, BY TISSUE, 2020–2026 (USD MILLION)
TABLE 209 ROW: CELL DISSOCIATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 210 ROW: CELL DISSOCIATION MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 211 ROW: CELL DISSOCIATION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 212 ROW: CELL DISSOCIATION MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 150)
11.1 OVERVIEW
FIGURE 23 KEY DEVELOPMENTS IN THE CELL DISSOCIATION MARKET,JANUARY 2018–APRIL 2021
FIGURE 24 MARKET EVOLUTION MATRIX: JANUARY 2018 TO APRIL 2021
11.2 MARKET SHARE ANALYSIS
TABLE 213 CELL DISSOCIATION MARKET: DEGREE OF COMPETITION
11.3 COMPANY EVALUATION MATRIX
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 25 VENDOR DIVE: CELL DISSOCIATION MARKET
11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS)
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 26 VENDOR DIVE MATRIX FOR SMES & START-UPS: CELL DISSOCIATION MARKET
11.5 COMPETITIVE SCENARIO
TABLE 214 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–APRIL 2021
11.5.1 DEALS
TABLE 215 KEY DEALS, JANUARY 2018–APRIL 2021
11.5.2 OTHER DEVELOPMENTS
TABLE 216 OTHER KEY DEVELOPMENTS, JANUARY 2018–APRIL 2021
11.6 COMPANY FOOTPRINT
TABLE 217 COMPANY FOOTPRINT
TABLE 218 COMPANY PRODUCT FOOTPRINT
TABLE 219 COMPANY CELL DISSOCIATION TYPE FOOTPRINT
TABLE 220 COMPANY GEOGRAPHICAL FOOTPRINT
12 COMPANY PROFILES (Page No. - 163)
12.1 KEY PLAYERS
(Business Overview, Products Offered, and Recent Developments)*
12.1.1 THERMO FISHER SCIENTIFIC
TABLE 221 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
12.1.2 MERCK KGAA
TABLE 222 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2020)
12.1.3 BECTON, DICKINSON AND COMPANY
TABLE 223 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
12.1.4 STEMCELL TECHNOLOGIES
TABLE 224 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
12.1.5 PROMOCELL GMBH
TABLE 225 PROMOCELL GMBH: BUSINESS OVERVIEW
12.1.6 F. HOFFMANN-LA ROCHE LTD.
TABLE 226 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
12.1.7 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 227 CYTIVA: BUSINESS OVERVIEW
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
12.1.8 MILTENYI BIOTEC
TABLE 228 MILTENYI BIOTEC: BUSINESS OVERVIEW
12.1.9 ATCC
TABLE 229 ATCC: BUSINESS OVERVIEW
12.1.10 CORNING INC.
TABLE 230 CORNING INC.: BUSINESS OVERVIEW
FIGURE 32 CORNING INC.: COMPANY SNAPSHOT (2020)
12.1.11 HIMEDIA LABORATORIES
TABLE 231 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
12.1.12 PAN-BIOTECH
TABLE 232 PAN-BIOTECH: BUSINESS OVERVIEW
12.1.13 ACCEGEN
TABLE 233 ACCEGEN: BUSINESS OVERVIEW
12.1.14 CELLSYSTEMS GMBH
TABLE 234 CELLSYSTEMS: BUSINESS OVERVIEW
12.1.15 AMSBIO
TABLE 235 AMSBIO: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 VITACYTE
TABLE 236 VITACYTE: BUSINESS OVERVIEW
12.2.2 ALSTEMBIO CELL ADVANCEMENT
TABLE 237 ALSTEM: BUSINESS OVERVIEW
12.2.3 BIOLOGICAL INDUSTRIES
TABLE 238 BIOLOGICAL INDUSTRIES: BUSINESS OVERVIEW
12.2.4 GEMINI BIO-PRODUCTS
TABLE 239 GEMINI BIO-PRODUCTS: BUSINESS OVERVIEW
12.2.5 INNOVATIVE CELL TECHNOLOGIES, INC.
TABLE 240 INNOVATIVE CELL TECHNOLOGIES, INC.: BUSINESS OVERVIEW
12.2.6 CENTRAL DRUG HOUSE (P) LTD.
TABLE 241 CENTRAL DRUG HOUSE (P) LTD.: BUSINESS OVERVIEW
12.2.7 R&D SYSTEMS (BIO-TECHNE)
TABLE 242 R&D SYSTEMS: BUSINESS OVERVIEW
12.2.8 WORTHINGTON BIOCHEMICAL CORPORATION
TABLE 243 WORTHINGTON BIOCHEMICAL CORPORATION: BUSINESS OVERVIEW
12.2.9 CAPRICORN SCIENTIFIC
TABLE 244 CAPRICORN SCIENTIFIC: BUSINESS OVERVIEW
12.2.10 ABEOMICS
TABLE 245 ABEOMICS: BUSINESS OVERVIEW
12.2.11 GENLANTIS
TABLE 246 GENLANTIS: BUSINESS OVERVIEW
12.2.12 NEUROMICS
TABLE 247 NEUROMICS: BUSINESS OVERVIEW
* Business Overview, Products Offered, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 212)
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the cell dissociation market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (pharmaceutical and biotechnology companies, Research and Accedemic institutes, Biopharamaceutical companies) and supply sides (cell dissiociation products manufacturers and distributors).
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell dissociation market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size-using the market size estimation processes-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell dissociation industry.
Report Objectives
- To define, describe, and forecast the global cell dissociation market based on product, tissue, type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
- To track and analyze competitive developments such as acquisitions, new product launches, expansions, regulatory approvals, and agreements in the cell dissociation market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis:
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis:
- Further breakdown of the Rest of the World cell dissociation market into Latin America, the Middle East, and Africa cell dissociation market into specific countries and further breakdown of the European cell dissociation market into specific countries
Growth opportunities and latent adjacency in Cell Dissociation Market